Patient compliance with inhaled medication therapy in chronic obstructive pulmonary disease;Estudio de cumplimiento del tratamiento por via inhalatoria en pacientes con enfermedad pulmonar obstructiva cronica

Archivos de Bronconeumologia

Volumn 36, Issue 6, 2000, Pages 319-325

  Viejo, J L ^a   Escribano, P Martín ^b   Romero, S ^c   Rodriguez Suarez J R ^d   Sobradillo, V ^e   Valencia, A ^f  

^a HOSPITAL UNIVERSITARIO DE BURGOS   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^d HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^e HOSPITAL DE CRUCES   (Spain)

^f HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

Compliance; COPD; Inhaled administration

Indexed keywords

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DRUG THERAPY; HUMAN; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE;

EID: 0033912026     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-2896(15)30151-4     Document Type: Article

References (17)

1. Murphy J, Coster G. Issues in patient compliance. Drugs 1997; 54: 767-800.
2. Mateos R, Camacho Álvarez M. Causas y consecuencias del incumplimiento de la prescripción médica. Med Clin (Barc) 1996; 10: 276-277.
3. Bosley CM, Parry DT, Cochrane GM. Patient compliance with inhaled medication. Does combining beta agonist with corticosteroids improve compliance? Eur Respir J 1994; 7: 504-509.
4. Haynes B, McKibbon KA, Kanani R. Systematic review of randomzied trials of intervention to assist patient to follow prescriptions for medications. Lancet 1996; 248: 383-386.
5. James PNE, Anderson JB, Prior JG. Patterns of drugs taking in patients with chronic airflow obstruction. Postgrad Med J 1985; 61: 7-10.
6. Dompleing E. Treatment with inhaled steroids in asthma and chronic bronchitis; long term compliance and inhaler technique. Fam Pract 1992; 9: 161-166.
7. Turner J, Wright E, Mendella L, Anthonisen N, e IPPB study group. Predictors of patient adherence to a long term home nebulizer therapy for COPD. Chest 1995; 108: 394-400.
8. Rand CS, para el Lung Heralth Study Research Group. Long term metered dose inhaler adherence in a clinical trial. Am J Respir Crit Care Med 1995; 152: 580-588.
9. Bosley CM, Corden ZM, Rees PJ, Cochrane GM. Physological factors associated with use for home nebulized therapy for COPD. Eur Respir J 1996; 6: 2346-2350.
10. Montemayor T, Alfejame I, Escudero C, Morera J, Sánchez L. Diagnóstico y tratamiento de la enfermedad pulmonar obstructiva crónica. Recomendaciones SEPAR. Barcelona: Ediciones Doyma, 1998; 115-146.
11. Moriski DE, Green LW, Levine M. Concurrent and predictive of a self reported measure of medication adherence. Med Care 1986; 24: 67-74.
12. Van der Palen J, Klein JJ, Roves MM. Compliance with inhaled medication and self-treatment guidelines following a self-management programme in adult asthmatics. Eur Respir J 1997; 10: 652-657.
13. Hyland ME. Types of non compliance. Eur Respir Rev 1998; 8: 255-259.
14. Jone PW. Heath status, quality of life and compliance. Eur Respir Rev 1998; 8: 243-246.
15. Viejo JL. Cumplimiento de la terapia inhalada en la EPOC. En: Viejo JL, editor. Nuevos problemas en neumología. Simposio de neumología. Burgos, 1998.
16. Marino JT. Enhancing patient compliance in asthma management Chest 1996; 10: 862.
17. Keller S. Implications of the stages of change Medel for medication compliance. Eur Respir Rev 1998; 8: 260-266.